Related Experiment Video
Updated: Aug 9, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss
S H Windahl1, K Hollberg, O Vidal
1Department of Biosciences, Karolinska Institutet, Novum, Huddinge, Sweden.
Abstract:
Recently, it has been shown that inactivation of estrogen receptor beta (ER-beta) by gene targeting results in increased cortical bone formation in adolescent female mice. To study the possible involvement of ER-beta in the regulation of the mature skeleton, we have extended the analyses to include 1-year-old ER-beta knockout mice (ER-beta-/-). Male ER-beta-/- mice did not express any significant bone phenotypic alterations at this developmental stage. However, the increase in cortical bone parameters seen already in the adolescent female ER-beta-/- mice was maintained in the older females. The aged female ER-beta-/- mice further exhibited a significantly higher trabecular bone mineral density (BMD) as well as increased bone volume/total volume (BV/TV) compared with wild-type (wt) mice. This was caused by a less pronounced loss of trabecular bone during adulthood in female ER-beta-/- mice. The growth plate width was unaltered in the female ER-beta-/- mice. Judged by the expression of the osteoclast marker tartrate-resistant acid phosphatase (TRAP) and cathepsin K (cat K; reverse-transcription-polymerase chain reaction [RT-PCR]) as well as the serum levels of C-terminal type I collagen cross-linked peptide, bone resorption appeared unaffected. However, an increase in the messenger RNA (mRNA) expression levels of the osteoblast marker core-binding factor alpha1 (Cbfa1) suggested an anabolic effect in bones of old female ER-beta-/- mice. In addition, the mRNA expression of ER-alpha was augmented, indicating a role for ER-alpha in the development of this phenotype. Taken together, the results show that ER-beta is involved in the regulation of trabecular bone during adulthood in female mice and suggest that ER-beta acts in a repressive manner, possibly by counteracting the stimulatory action of ER-alpha on bone formation.
Insights
Estrogen receptor beta (ER-beta) inactivation boosts bone density in mature female mice. This suggests ER-beta negatively regulates adult bone mass, potentially by opposing estrogen receptor alpha (ER-alpha) effects.
Area of Science:
- Endocrinology
- Bone Biology
- Genetics
Background:
- Estrogen receptor beta (ER-beta) gene inactivation increases cortical bone in adolescent female mice.
- The role of ER-beta in the mature skeleton remains to be fully elucidated.
Purpose of the Study:
- To investigate the role of ER-beta in regulating the mature skeleton in mice.
- To determine if ER-beta influences bone parameters in adult female mice.
Main Methods:
- Analysis of 1-year-old ER-beta knockout (ER-beta-/-) mice compared to wild-type (wt) littermates.
- Assessment of cortical and trabecular bone parameters, including bone mineral density (BMD) and bone volume/total volume (BV/TV).
- Evaluation of gene expression for osteoblast (Cbfa1) and osteoclast (TRAP, cat K) markers, and estrogen receptor alpha (ER-alpha) mRNA.
Main Results:
- Male ER-beta-/- mice showed no significant bone alterations at this stage.
- Female ER-beta-/- mice maintained increased cortical bone and exhibited higher trabecular BMD and BV/TV compared to wt mice.
- Reduced trabecular bone loss during adulthood and increased osteoblast marker Cbfa1 mRNA expression were observed in female ER-beta-/- mice, alongside augmented ER-alpha mRNA expression.
Conclusions:
- ER-beta plays a role in regulating trabecular bone mass during adulthood in female mice.
- ER-beta appears to act repressively on bone, potentially by counteracting the stimulatory effects of ER-alpha on bone formation.
- These findings highlight ER-beta as a potential target for managing bone loss in mature females.

